- Filed
- Mar 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Dec 31, 2024 | 84.06M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $172.82M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $396.29M |
| Current Assets | FY 2024 · Dec 31, 2023 | $921.95M |
| Total Assets | FY 2024 · Dec 31, 2023 | $2.2B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 104.42M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $15.37M |
| Capex restated | FY 2024 · Dec 31, 2022 | $0 |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $199.15M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $0.76 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $0.77 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $57.55M |
| Net Income | FY 2024 · Dec 31, 2022 | $78.41M |
| Operating Income | FY 2024 · Dec 31, 2022 | $245.77M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $495.6M |
| Revenue | FY 2024 · Dec 31, 2022 | $1.19B |
| Cash And Equivalents | FY 2024 · Dec 31, 2021 | $108.98M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $2.43B |